Circulating and intestinal regulatory T cells in inflammatory bowel disease: A systemic review and meta-analysis

References

• de Souza HS, Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol. 2016;13(1):13–27. doi:10.1038/nrgastro.2015.186.
   PubMed Web of Science ®Google Scholar
• Geremia A, Biancheri P, Allan P, et al. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev. 2014;13(1):3–10. doi:10.1016/j.autrev.2013.06.004.
   PubMed Web of Science ®Google Scholar
• Mayne CG, Williams CB. Induced and natural regulatory T cells in the development of inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(8):1772–1788. doi:10.1097/MIB.0b013e318281f5a3.
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 + CD25+ regulatory T cells. Nat Immunol. 2003;4(4):330–336. doi:10.1038/ni904.
   PubMed Web of Science ®Google Scholar
• Khattri R, Cox T, Yasayko SA, et al. An essential role for Scurfin in CD4 + CD25+ T regulatory cells. Nat Immunol. 2003;4(4):337–342. doi:10.1038/ni909.
   PubMed Web of Science ®Google Scholar
• Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006;203(7):1701–1711. doi:10.1084/jem.20060772.
   PubMed Web of Science ®Google Scholar
• Abbas AK, Benoist C, Bluestone JA, et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol. 2013;14(4):307–308. doi:10.1038/ni.2554.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kang SG, Kim CH. FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J Immunol. 2007;178(1):301–311. doi:10.4049/jimmunol.178.1.301.
   PubMed Web of Science ®Google Scholar
• Johansson-Lindbom B, Svensson M, Wurbel MA, et al. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med. 2003;198(6):963–969. doi:10.1084/jem.20031244.
   PubMed Web of Science ®Google Scholar
• Johansson-Lindbom B, Svensson M, Pabst O, et al. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J Exp Med. 2005;202(8):1063–1073. doi:10.1084/jem.20051100.
   PubMed Web of Science ®Google Scholar
• Siewert C, Menning A, Dudda J, et al. Induction of organ-selective CD4+ regulatory T cell homing. Eur J Immunol. 2007;37(4):978–989. doi:10.1002/eji.200636575.
   PubMed Web of Science ®Google Scholar
• Jacobse J, Li J, Rings E, et al. Intestinal regulatory T cells as specialized tissue-restricted immune cells in intestinal immune homeostasis and disease. Front Immunol. 2021;12:716499. doi:10.3389/fimmu.2021.716499.
   PubMed Web of Science ®Google Scholar
• Boschetti G, Kanjarawi R, Bardel E, et al. Gut Inflammation in mice triggers proliferation and function of mucosal Foxp3+ regulatory T cells but impairs their conversion from CD4+ T cells. J Crohns Colitis. 2017;11(1):105–117. doi:10.1093/ecco-jcc/jjw125.
   PubMed Web of Science ®Google Scholar
• Elinav E, Waks T, Eshhar Z. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice. Gastroenterology. 2008;134(7):2014–2024. doi:10.1053/j.gastro.2008.02.060.
   PubMed Web of Science ®Google Scholar
• Ostanin DV, Bao J, Koboziev I, et al. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol. 2009;296(2):G135–46. doi:10.1152/ajpgi.90462.2008.
   PubMed Web of Science ®Google Scholar
• Fantini MC, Monteleone G. Update on the therapeutic efficacy of tregs in IBD: thumbs up or thumbs down? Inflamm Bowel Dis. 2017;23(10):1682–1688. doi:10.1097/MIB.0000000000001272.
   PubMed Web of Science ®Google Scholar
• Boschetti G, Nancey S, Sardi F, et al. Therapy with anti-TNFalpha antibody enhances number and function of Foxp3+ regulatory T cells in inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17(1):160–170. doi:10.1002/ibd.21308.
   PubMed Web of Science ®Google Scholar
• Chao K, Zhang S, Yao J, et al. Imbalances of CD4+ T-cell subgroups in Crohn’s disease and their relationship with disease activity and prognosis. J Gastroenterol Hepatol. 2014;29(10):1808–1814. doi:10.1111/jgh.12592.
   PubMed Web of Science ®Google Scholar
• Chao K, Zhong BH, Zhang SH, et al. Imbalance of CD4 + T cell subgroups in ulcerative colitis. Natl Med J China. 2011;91:1605–1608. doi:10.3760/cma.j.issn.0376-2491.2011.23.006.
   Google Scholar
• Chamouard P, Monneaux F, Richert Z, et al. Diminution of circulating CD4 + CD25 high T cells in naïve Crohn’s disease. Dig Dis Sci. 2009;54(10):2084–2093. doi:10.1007/s10620-008-0590-6.
   PubMed Web of Science ®Google Scholar
• Kamikozuru K, Fukunaga K, Hirota S, et al. The expression profile of functional regulatory T cells, CD4 + CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease. Clin Exp Immunol. 2009;156(2):320–327. doi:10.1111/j.1365-2249.2009.03904.x.
   PubMed Web of Science ®Google Scholar
• Mitsialis V, Wall S, Liu P, et al. Single-cell analyses of colon and blood reveal distinct immune cell signatures of ulcerative colitis and Crohn’s disease. Gastroenterology. 2020;159(2):591–608.e10. doi:10.1053/j.gastro.2020.04.074.
   PubMed Web of Science ®Google Scholar
• Saruta M, Yu QT, Fleshner PR, et al. Characterization of FOXP3 + CD4+ regulatory T cells in Crohn’s disease. Clin Immunol. 2007;125(3):281–290. doi:10.1016/j.clim.2007.08.003.
   PubMed Web of Science ®Google Scholar
• Ueno A, Jijon H, Chan R, et al. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Inflamm Bowel Dis. 2013;19(12):2522–2534. doi:10.1097/MIB.0b013e3182a85709.
   PubMed Web of Science ®Google Scholar
• Maul J, Loddenkemper C, Mundt P, et al. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology. 2005;128(7):1868–1878. doi:10.1053/j.gastro.2005.03.043.
   PubMed Web of Science ®Google Scholar
• Mohammadnia-Afrouzi M, Hosseini AZ, Khalili A, et al. Decrease of CD4+ CD25+ CD127low FoxP3+ regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients. Autoimmunity. 2015;48(8):556–561. doi:10.3109/08916934.2015.1070835.
   PubMed Web of Science ®Google Scholar
• Yu QT, Saruta M, Avanesyan A, et al. Expression and functional characterization of FOXP3 + CD4 + regulatory T cells in ulcerative colitis. Inflamm Bowel Dis. 2007;13(2):191–199. doi:10.1002/ibd.20053.
   PubMed Web of Science ®Google Scholar
• Jaeger N, Gamini R, Cella M, et al. Single-cell analyses of Crohn’s disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions. Nat Commun. 2021;12(1):1921. doi:10.1038/s41467-021-22164-6.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi:10.1007/s10654-010-9491-z.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558. doi:10.1002/sim.1186.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi:10.1136/bmj.327.7414.557.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. doi:10.1136/bmj.315.7109.629.
   PubMed Web of Science ®Google Scholar
• Hattori S, Zhou XH. Sensitivity analysis for publication bias in meta-analysis of diagnostic studies for a continuous biomarker. Stat Med. 2018;37(3):327–342. doi:10.1002/sim.7510.
   PubMed Web of Science ®Google Scholar
• Gong Y, Lin Y, Zhao N, et al. The Th17/Treg immune imbalance in ulcerative colitis disease in a chinese han population. Mediators Inflamm. 2016;2016:7089137. doi:10.1155/2016/7089137.
   PubMed Web of Science ®Google Scholar
• Karczewski J, Karczewski M. Possible defect of regulatory T cells in patients with ulcerative colitis. Central-European Journal of Immunology. 2011;36:254–255.
   Web of Science ®Google Scholar
• Khalili A, Ebrahimpour S, Maleki I, et al. CD4 + CD25 + CD127low FoxP3+ regulatory T cells in Crohn’s disease. Rom J Intern Med. 2018;56(3):158–166. doi:10.2478/rjim-2018-0006.
   PubMed Web of Science ®Google Scholar
• Lin QR, Xia XP, Cai XN, et al. Association of Breg cells and Treg cells with the clinical effects of Infliximab in the treatment of Chinese patients with Crohn’s disease. Zhonghua yi Xue za Zhi. 2020;100:3303–3308. doi:10.3760/cma.j.cn112137-20200215-00298.
   PubMedGoogle Scholar
• Wang Y, Liu XP, Zhao ZB, et al. Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease. J Dig Dis. 2011;12(4):286–294. doi:10.1111/j.1751-2980.2011.00505.x.
   PubMed Web of Science ®Google Scholar
• Yokoyama Y, Fukunaga K, Fukuda Y, et al. Demonstration of low-regulatory CD25(High+) CD4+ and high-pro-inflammatory CD28- CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption Apheresis. Dig Dis Sci. 2007;52(10):2725–2731. doi:10.1007/s10620-006-9560-z.
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989;298(6666):82–86. doi:10.1136/bmj.298.6666.82.
   PubMed Web of Science ®Google Scholar
• Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994;330(26):1841–1845. doi:10.1056/nejm199406303302601.
   PubMed Web of Science ®Google Scholar
• Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2(4947):1041–1048. doi:10.1136/bmj.2.4947.1041.
   PubMed Web of Science ®Google Scholar
• Sutherland LR, Martin F, Greer S, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 1987;92(6):1894–1898. doi:10.1016/0016-5085(87)90621-4.
   PubMed Web of Science ®Google Scholar
• Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn’s disease activity index (CDAI). Gastroenterology. 1979;77(4 Pt 2):843–846. doi:10.1016/0016-5085(79)90384-6.
   PubMed Web of Science ®Google Scholar
• Elliott PR, Lennard-Jones JE, Hathway N. Simple index of Crohn’s disease activity. Lancet. 1980;1(8173):876. doi:10.1016/s0140-6736(80)91372-0.
   PubMed Web of Science ®Google Scholar
• Bin Dhuban K, Kornete M, Sm E, et al. Functional dynamics of Foxp3+ regulatory T cells in mice and humans. Immunol Rev. 2014;259(1):140–158. doi:10.1111/imr.12168.
   PubMed Web of Science ®Google Scholar
• Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med. 2006;203(7):1693–1700. doi:10.1084/jem.20060468.
   PubMed Web of Science ®Google Scholar
• Best WR. Predicting the Crohn’s disease activity index from the Harvey-Bradshaw Index. Inflamm Bowel Dis. 2006;12(4):304–310. doi:10.1097/01.MIB.0000215091.77492.2a.
   PubMed Web of Science ®Google Scholar
• Guidi L, Felice C, Procoli A, et al. FOXP3+ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents. Biomed Res Int. 2013;2013:286368. doi:10.1155/2013/286368.
   PubMed Web of Science ®Google Scholar
• Rosseto-Welter EA, D'Argenio-Garcia L, Blasco Tavares Pereira Lopes F, et al. Biologic Agents in Crohn’s Patients Reduce CD4 + T Cells Activation and Are Inversely Related to Treg Cells. Can J Gastroenterol Hepatol. 2022;2022:1307159. doi:10.1155/2022/1307159.
   PubMed Web of Science ®Google Scholar
• Cosovanu C, Neumann C. The many functions of Foxp3(+) regulatory T cells in the intestine. Front Immunol. 2020;11:600973. doi:10.3389/fimmu.2020.600973.
   PubMed Web of Science ®Google Scholar
• Butera A, Sanchez M, Pronio A, et al. CD3 + CD4 + LAP + Foxp3-regulatory cells of the colonic lamina propria limit disease extension in ulcerative colitis. Front Immunol. 2018;9:2511. doi:10.3389/fimmu.2018.02511.
   PubMed Web of Science ®Google Scholar
• Tiwari V, Kedia S, Garg SK, et al. CD4+ CD25+ FOXP3+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn’s disease. PLoS One. 2018;13(2):e0193433. doi:10.1371/journal.pone.0193433.
   PubMed Web of Science ®Google Scholar
• Fiyouzi T, Pelaez-Prestel HF, Reyes-Manzanas R, et al. Enhancing regulatory T cells to treat inflammatory and autoimmune diseases. Int J Mol Sci. 2023;24(9):7797. doi:10.3390/ijms24097797.
   PubMed Web of Science ®Google Scholar